SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-040498
Filing Date
2021-08-04
Accepted
2021-08-04 07:22:04
Documents
104
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q hznp-10q_20210630.htm   iXBRL 10-Q 5240039
2 EX-31.1 hznp-ex311_702.htm EX-31.1 16079
3 EX-31.2 hznp-ex312_701.htm EX-31.2 15832
4 EX-32.1 hznp-ex321_699.htm EX-32.1 8964
5 EX-32.2 hznp-ex322_700.htm EX-32.2 8985
  Complete submission text file 0001564590-21-040498.txt   17709317

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA hznp-20210630.xsd EX-101.SCH 104187
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hznp-20210630_cal.xml EX-101.CAL 83413
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hznp-20210630_def.xml EX-101.DEF 383572
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hznp-20210630_lab.xml EX-101.LAB 706257
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hznp-20210630_pre.xml EX-101.PRE 610998
11 EXTRACTED XBRL INSTANCE DOCUMENT hznp-10q_20210630_htm.xml XML 3691369
Mailing Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4
Business Address CONNAUGHT HOUSE, 1ST FLOOR 1 BURLINGTON ROAD DUBLIN L2 4 011-353-1-772-2100
Horizon Therapeutics Public Ltd Co (Filer) CIK: 0001492426 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35238 | Film No.: 211142338
SIC: 2834 Pharmaceutical Preparations